The Charles Bronfman Institute for Personalized Medicine is directed by two accomplished young leaders in the Mount Sinai Health System.

Alexander Charney, MD, PhD, is a psychiatrist, geneticist, neuroscientist, and data scientist.  He is an expert on the genetic architecture of mental illness and is known for encouraging colleagues in this field to strive for clinical relevance.

Dr. Charney emerged as a leader of Mount Sinai’s research response to the COVID-19 pandemic, bringing together hundreds of scientists and clinicians to work on turning the tide of the pandemic. He is the primary investigator on Mount Sinai’s successful bid to become a site for RECOVER, the National Institutes of Health initiative to characterize the long-term health effects of COVID-19.

Robbie Freeman, RN, MSN, NE-BC, is Vice President of Clinical Innovation and Chief Nursing Informatics Officer (CNIO) at the Mount Sinai Health System and has held many leadership roles at Mount Sinai with a focus on quality, technology, and hospital operations.

Mr. Freeman drives IPM technology strategy to support patient care across the hospital and ambulatory care settings, leveraging technology such as machine learning, artificial intelligence, and virtual care.

Dara Meyer, MS, PMP, is the Director of Operations and Project Management for IPM with wide-ranging experience managing multifaceted, high-impact initiatives within the Mount Sinai Health System.

Ms. Meyer has a proven track record for developing high impact programs with a special emphasis on the creation of production-ready processes and infrastructure, effective resource management, and team collaboration. She is the lead program manager for key programs such as RECOVER and manages daily operations for IPM.